NCT07143071

EndoVascular Aortic Dissection Early vs Delayed

Endovascular Treatment for Acute High-risk Type B Aortic Dissection in Acute VS Subacute Phase: a Prospective, Multicenter, Non-inferior, Parallel Controlled Trial

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 4,068 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, multicenter, non-inferior, parallel-controlled observational study. This study aims to compare clinical outcomes of endovascular treatment for acute high-risk type B aortic dissection in the acute phase versus the subacute phase. No interventions will be imposed on the patients' standard treatment. Patients with acute high-risk type B aortic dissection will be grouped based on the actual timing of their treatment.

Conditions

• Aortic Dissection Type B

Interventions

Type	Name	Description
PROCEDURE	Acute Phase	Patients with acute high-risk type B aortic dissection received endovascular treatment in acute phase (2-14days)
PROCEDURE	Subacute Phase	Patients with acute high-risk type B aortic dissection received endovascular treatment in subacute phase (≥14days)

Timeline

• Start date: 2025-07-01
• Primary completion: 2028-07-31
• Completion: 2030-07-31
• First posted: 2025-08-27
• Last updated: 2025-08-27

Locations

1 site across 1 country: China